PARASITICIDE

PURPOSE:To obtain an endoparasiticide for an oral or endermic administration, containing a natural pyrethroid compound or a synthetic pyrethroid compound as an active component. CONSTITUTION:This parasiticide contains a natural pyrethroid compound or a synthetic pyrethroid compound of formula (R1 is...

Full description

Saved in:
Bibliographic Details
Main Authors UDAGAWA TAKATOSHI, ONUMA KAZUTOMI, NAKAMURA MASAHIKO, FUJITA TAKASHI
Format Patent
LanguageEnglish
Published 05.09.1995
Edition6
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:PURPOSE:To obtain an endoparasiticide for an oral or endermic administration, containing a natural pyrethroid compound or a synthetic pyrethroid compound as an active component. CONSTITUTION:This parasiticide contains a natural pyrethroid compound or a synthetic pyrethroid compound of formula (R1 is a lower alkyl, a lower alkoxy or a lower haloalkoxy; R2 is a lower alkyl or a lower haloalkoxy; R3 is a lower alkyl or H; A is C or Si; B is O or CH2; X is H or a halogen; Y is H or a halogen) as an active component by 0.01-99wt.%, preferably 0.01-20wt.%. Its dosage is 0.001-10000mg/kg per day for an oral dose, and 0.001-10000mg/kg per day for a parenteral dose. It manifests a parasiticidic efficacy to not only parasites living in bodies of an intermediate host and a final host but also those of a reservoir host.
Bibliography:Application Number: JP19940313200